| Followers | 22 |
| Posts | 1382 |
| Boards Moderated | 0 |
| Alias Born | 05/10/2019 |
Thursday, August 22, 2024 6:54:09 PM
Convertible Debt holders do NOT sell at a loss. The way this game works is that the CD folks are issued heavily discounted shares, often 50% or more, in exchange for cash. Hypothetically, CD holder Steve gives RONN $50k in cash and Steve gets 50mm shares of RONN at a cost basis of .001 (50% discount from today’s share price).
Now is where the fun begins.
Part of Steve’s deal in loaning RONN the cash is that not only does Steve get the shares but he is often paid interest for the loan. Of course RONN has exactly zero revenue so the interest payments are sourced by robbing Peter and Paul to pay the interest owed to Steve.
So beyond some nice interest payments to Steve, RONN will put out PRs that are intended to pump the stock for Steve to dump. When a PR is issued, ideally sending RONN shares higher, Steve will begin to offload shares. Having received shares at .001 if RONN goes to .0028 that is a nearly 200% profit for Steve.
What is happening now is RONN’s PRs are falling flat and barely moving the share price. Therefore Steve (the CD holders) are getting impatient and want to be sure they protect their profits.
Bottom line is that Steve and the proverbial Convertible Debt folks know that RONN will never fulfill the nonsense claimed in PRs but they know there is a good likelihood they can capitalize offering financial services to RONN, the same financial services that banks or legit venture capital wouldn’t dare provide because RONN is a scam.
Now is where the fun begins.
Part of Steve’s deal in loaning RONN the cash is that not only does Steve get the shares but he is often paid interest for the loan. Of course RONN has exactly zero revenue so the interest payments are sourced by robbing Peter and Paul to pay the interest owed to Steve.
So beyond some nice interest payments to Steve, RONN will put out PRs that are intended to pump the stock for Steve to dump. When a PR is issued, ideally sending RONN shares higher, Steve will begin to offload shares. Having received shares at .001 if RONN goes to .0028 that is a nearly 200% profit for Steve.
What is happening now is RONN’s PRs are falling flat and barely moving the share price. Therefore Steve (the CD holders) are getting impatient and want to be sure they protect their profits.
Bottom line is that Steve and the proverbial Convertible Debt folks know that RONN will never fulfill the nonsense claimed in PRs but they know there is a good likelihood they can capitalize offering financial services to RONN, the same financial services that banks or legit venture capital wouldn’t dare provide because RONN is a scam.
Recent AIMN News
- Aimwell Bio Highlights Verified Biopharma Intelligence Network Strategy Amid Growing AI Trust Concerns (AIMN) • IH Market News • 05/27/2026 03:17:48 PM
- Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself • ACCESS Newswire • 05/27/2026 12:30:00 PM
- The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI • ACCESS Newswire • 05/20/2026 12:30:00 PM
- Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians • ACCESS Newswire • 05/18/2026 12:30:00 PM
- The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. • ACCESS Newswire • 05/13/2026 12:30:00 PM
- Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones • ACCESS Newswire • 05/11/2026 12:30:00 PM
- While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. • ACCESS Newswire • 05/06/2026 12:30:00 PM
- AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape • ACCESS Newswire • 05/04/2026 12:30:00 PM
- AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings • ACCESS Newswire • 04/27/2026 12:30:00 PM
- Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure • ACCESS Newswire • 04/22/2026 12:30:00 PM
- Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma • ACCESS Newswire • 04/20/2026 12:30:00 PM
- AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio • ACCESS Newswire • 04/15/2026 12:30:00 PM
